Главная Назад


Авторизация
Идентификатор пользователя / читателя
Пароль (для удалённых пользователей)
 

Вид поиска

Область поиска
в найденном
Найдено в других БД
Формат представления найденных документов:
библиографическое описание краткийполный
Отсортировать найденные документы по:
авторузаглавиюгоду изданиятипу документа
Поисковый запрос: (<.>S=ОТВЕТ НА ЛЕЧЕНИЕ<.>)
Общее количество найденных документов : 70
Показаны документы с 1 по 20
 1-20    21-40   41-60   61-70 
1.
A colorectal cancer classification system that associates cellular phenotype and responses to therapy // Nature Med., 2013. Vol. 19, N 5.-С.619-625

2.
A colorectal cancer classification system that associates cellular phenotype and responses to therapy // Nature Med., 2013. Vol. 19, N 5.-С.619-625

3.
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors // Int. J. Cancer, 2012. Vol. 130, N 6.-С.1357-1366

4.
A preclinical algorithm of soluble surrogate biomarkers that correlate with therapeutic inhibition of the MET oncogene in gastric tumors // Int. J. Cancer, 2012. Vol. 130, N 6.-С.1357-1366

5.
Autoimmune hemolytic anemia in patients with non-Hodgkin's lymphoma: Characteristics and significance // Ann. Oncol., 2000. Vol. 11, N 12.-С.1571-1577

6.
Robinson M.R.G. Carcinoma of the prostate. Objective criteria of response // Amer. J. Clin. Oncol., 1988. Vol. 11, Suppl. N2.-С.48-52

7.
CCNU (lomustine), idarubicin and dexamethasone (CIDEX): An effective oral regimen for the treatment of refractory or repalsed myeloma // Brit. J. Haematol., 2000. Vol. 109, N 3.-С.571-575

8.
CCNU (lomustine), idarubicin and dexamethasone (CIDEX): An effective oral regimen for the treatment of refractory or repalsed myeloma // Brit. J. Haematol., 2000. Vol. 109, N 3.-С.571-575

9.
Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5

10.
Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5

11.
Combined progesterone and oestrogen receptor (PR and ER) status in predicting hormone sensitive breast cancer: Better than ER alone? // J. Pathol., 1997. Vol. 181, Suppl..-С.5

12.
Comparison of EBV DNA viral load in whole blood, plasma, B-cells and B-cell culture supernatant // J. Med. Virol., 2014. Vol. 86, N 5.-С.851-856

13.
Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens // Brit. J. Haematol., 2005. Vol. 130, N 3.-С.363-372

14.
Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens // Brit. J. Haematol., 2005. Vol. 130, N 3.-С.363-372

15.
Does genotype predict response to treatment in children infected with hepatitis B perinatally? // J. Med. Virol., 2012. Vol. 84, N 10.-С.1535-1540

16.
Does genotype predict response to treatment in children infected with hepatitis B perinatally? // J. Med. Virol., 2012. Vol. 84, N 10.-С.1535-1540

17.
Does genotype predict response to treatment in children infected with hepatitis B perinatally? // J. Med. Virol., 2012. Vol. 84, N 10.-С.1535-1540

18.
Franchini L. Familial concordance of SSRIs response as a tool for differentiating mood disorder pedigrees // Amer. J. Med. Genet., 2000. Vol. 96, N 4.-С.536

19.
FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35

20.
FGF8 mRNA expression in benign and malignant prostate relationship to androgen receptor status // J. Pathol., 1997. Vol. 181, Suppl..-С.35

 1-20    21-40   41-60   61-70 
 




© Международная Ассоциация пользователей и разработчиков электронных библиотек и новых информационных технологий
(Ассоциация ЭБНИТ)